Explore our foundational bile acid derivatives and cholesterol standards optimized for Czech pharmaceutical research and commercial production.
Cholic acid and its derivative series—including Deoxycholic Acid, Ursodeoxycholic Acid (UDCA), and conjugated taurine/glycine salts—represent crucial physiological molecules with expanding applications. In the human body, bile acids acts as biological detergents that facilitate fat emulsification, cholesterol homeostasis, and lipid absorption.
Within the modern pharmaceutical framework, these properties are harnessed to develop highly specialized therapeutics. Ursodeoxycholic Acid, for example, is globally recognized as the gold standard for treating primary biliary cholangitis (PBC) and dissolving cholesterol-rich gallstones. Emerging clinical research also demonstrates that bile acids play key regulatory roles in metabolic pathways, acting as ligands for the nuclear Farnesoid X Receptor (FXR) and the G protein-coupled receptor TGR5.
Czech Republic’s robust pharmaceutical infrastructure—concentrated in regions like Prague and South Moravia—requires access to exceptionally pure biological raw materials that comply strictly with the European Pharmacopoeia (Ph. Eur.) and EU GMP standards. Our cholic acid series is manufactured to fulfill these demanding criteria.
The Czech Republic is a recognized hub for life sciences and clinical research in CEE. Industrial demand for high-purity bile acid salts has shifted from basic pharmaceutical preparations to targeted drug delivery systems. Complex conjugates like Sodium Tauroursodeoxycholate are studied for neuroprotective mechanisms and micellar encapsulation protocols.
Compliance Standard: ISO9001, Kosher, Halal, FDA registered facility, complying with EP/USP chemical monographs.
The production of bile acids demands advanced chemical synthesis combined with natural biological extraction. Historically, sourcing bovine or porcine raw materials has faced significant yield and traceability challenges. Chengdu Chenlv Herb Co., Ltd. resolves these issues by utilizing highly standardized extraction technologies at our Sichuan-based manufacturing facility.
Our regional supply chains benefit from two primary advantages:
A premier high-tech enterprise specializing in R&D, manufacturing, and global sales of premium botanical extracts and natural pharmaceutical ingredients.
Established in 2012, Chenlv Herb operates a state-of-the-art facility designed to deliver high-purity, highly active, and premium-grade natural materials to the global life sciences sector. Our comprehensive product portfolio serves client industries spanning pharmaceuticals, nutraceuticals, advanced animal nutrition, and biological research.
We integrate rigid quality control protocols with innovative extraction methodologies. Our strategic goal is to support the research and development programs of international partners by offering tailor-made manufacturing options, custom packaging, and comprehensive regulatory documentation.
Established as a High-Tech Enterprise
Consistently delivering beyond expectations with advanced manufacturing capabilities and customized options.
We develop high-yield synthetic routes and crystallization techniques to elevate purity profiles and customize bile acid chemical structures to your specification.
Streamlined logistics and high-volume production structures allow rapid, secure exports directly to major logistics terminals in the Czech Republic.
We source natural biological inputs via strict animal welfare-compliant agricultural systems, utilizing green chemical synthesis routes whenever possible.
Our regulatory support team assists with DMF filings, CEP documentation, and analytical validation profiles to ease registration with regulatory bodies.
Every single batch undergoes rigorous HPLC, GC, and ICP-MS testing to verify purity levels, organic solvents, and heavy metals content.
Deep expertise in biological extraction and chemical modification allows us to address complex purification issues and scaling bottlenecks efficiently.
Get quarterly reports on raw material availability, pricing forecasts, and regulatory changes in Central Europe.
Understanding how our high-purity Cholic Acid series integrates with regional technological and industrial pipelines.
Integrating natural bile extracts into digestive enzyme formulations and liver support supplements based on traditional concepts updated for modern health needs.
Read More →
Employing active bile acid APIs (UDCA, CDCA, Deoxycholic Acid) to formulate innovative treatments for cholestatic diseases, lipid disorders, and advanced drug delivery micelles.
Read More →
Leveraging the natural emulsifying properties of sodium deoxycholate to develop skin-soothing formulations, advanced bio-cosmetics, and localized fat tissue research reagents.
Read More →
Utilizing targeted bile acid additives to optimize lipid absorption, improve hepatobiliary wellness, and increase overall performance in aquaculture and commercial livestock feed.
Read More →A step-by-step approach ensuring consistent chemical structures, physical attributes, and regulatory compliance.
Aligning target purities, packaging styles, and documentation needs.
Providing clear pricing options for different synthesis volumes.
Formalizing mutual agreements regarding lead times and QA profiles.
Manufacturing first-article pilot samples for testing.
Executing batch orders within our GMP facility.
Releasing final certificate of analysis (CoA) documentation.
Delivering securely packaged products directly to Czech facilities.
Our production facilities operate in strict compliance with globally recognized quality standards.
Stay informed about global trends, price dynamics, and technical developments in the biological extracts sector.
Explore how supply dynamics and raw material pricing affect standard extraction yields, and learn what strategies pharmaceutical buyers are using to mitigate sourcing risks.
Join our technical team at CPHI China to discuss next-generation synthesis techniques for bile derivatives and meet with our research leads.
Discover our latest compliance document structures, high-purity APIs, and chemical synthesis pathways at the upcoming international forum.
Understanding regulatory details, packaging options, and logistics protocols for shipments to Central Europe.
Our standard pharmaceutical-grade Ursodeoxycholic Acid and Deoxycholic Acid achieve a purity profile of ≥98.5% measured via HPLC. We also supply custom analytical standards reaching ≥99% purity for lab validation programs.
We source raw bovine and porcine bile exclusively from certified veterinary-inspected abattoirs. Every shipment includes comprehensive veterinary clearances and BSE/TSE-free certificates, ensuring full alignment with EU import rules.
Yes. We supply comprehensive regulatory support packages, including DMF (Drug Master File) directories, Technical Dossiers, safety sheets (MSDS), detailed Certificates of Analysis (CoA) for each batch, and ISO validation profiles.
Our typical bulk packaging features 25kg fiber drums lined with dual polyethylene food-grade protective bags. For specialized applications, we can prepare custom configurations from 1kg to 10kg, complete with inert gas sealing.
Standard inventory materials ship within 3–5 working days from our warehouse. High-volume bulk orders or custom synthesis configurations typically ship within 3–5 weeks, depending on synthesis complexity and validation needs.
We maintain multi-year raw material procurement contracts and operate a high-capacity production facility. This stable production baseline allows us to cushion price movements and offer reliable annual pricing structures to our regular partners.
Select specialized chemical structures and sodium salts for diagnostic reagents, drug formulations, and biochemical assays.
